Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics.

https://www.businesswire.com/news/home/20211014005033/en/Tentarix-Biotherapeutics-Emerges-with-50-Million-Series-A

Versant Ventures

Samsara BioCapital

Tentarix Biotherapeutics

Exciting news: Tentarix and AbbVie are joining forces to potentially revolutionize oncology and immunology treatment through conditionally-active multi-specific biologics. Read more about our groundbreaking collaboration: https://lnkd.in/gn2_DhiW

We are #Hiring! Several incredible opportunities are available on our growing team. Currently accepting applications from creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. 

Explore all job openings and apply here: https://lnkd.in/gF57EJP8

The excitement around our Tentacles™ platform continues to grow! Today we announced the completion of our Series B financing, bringing total equity and upfront deal consideration to $132 Million.

Catch up on our Series B details here: https://lnkd.in/gM34hP4k

We're #hiring creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. We've launched some exciting news this week too! 

Check out our new collaboration: 
https://lnkd.in/gzXY9dSM

Apply here:
https://lnkd.in/g2eYMRN7

🔬 Delighted to share news of our collaboration, leveraging our Tentacles platform to develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases! Dive into the details through the link below.
https://lnkd.in/gzXY9dSM

Univercells is a company that focuses on innovative bioprocessing technologies and solutions.

Univercells

Synthego is a leading provider of genome engineering solutions and services.

Synthego

Sutro Biopharma is a company dedicated to developing best-in-class antibody-drug conjugate and multi-specific antibody-based therapeutics.

Sutro Biopharma

Cibus is a biotechnology company that develops and markets advanced traits for the global seed industry.

Cibus

EvoNetix is a company that specializes in the development of novel gene synthesis technologies.

EvoNetix

Mogrify is a biotechnology company focused on the transformation of the development of ex vivo cell therapies.

Mogrify

Vividion is a biotechnology company that specializes in the discovery of highly selective small molecule drugs.

Vividion

Richcore Lifesciences is a biotechnology company known for its innovative bioprocessing solutions.

Richcore Lifesciences

AbbVie is a global biopharmaceutical company known for its focus on developing advanced therapies.

AbbVie

DiaCarta is a company specializing in the development of innovative molecular diagnostics.

DiaCarta

Mission Bio is a company known for its advanced single-cell genomics solutions.

Mission Bio

Quadrants Scientific is a company that provides advanced scientific and laboratory solutions.

Quadrants Scientific

Tentarix is a technology company that specializes in providing innovative software solutions aimed at enhancing business processes and customer experiences. The company leverages cutting-edge technologies to deliver products that cater to a diverse clientele across various industries.

Tentarix

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

news impact assignment basic	general
public peers	general	May 16, 2024 8:59 AM	405c90cc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 16, 2024 8:59 AM	581aa4c2
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:TENTARIX

Tentarix